Clarity Medical Group Holding Limited provided consolidated earnings guidance for the six months ended 30 September 2022. For the period, the company expects a decrease in profit attributable to owners of the Company in a range of approximately HKD 2.3 million to HKD 3.8 million for the Interim Period as compared to the same period in 2021, representing an expected drop of approximately 21% to 34%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.495 HKD | 0.00% | -1.00% | -21.43% |
05-29 | Clarity Medical Group Holding Limited Appoints Cheng Jessica as Independent Non-Executive Director and Audit Committee | CI |
05-24 | Clarity Medical to Widen Loss in Fiscal 2024 | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.43% | 33.52M | |
-25.47% | 15B | |
-1.80% | 11.99B | |
+3.48% | 11.7B | |
+27.55% | 8.59B | |
-6.29% | 7.5B | |
+6.10% | 6.71B | |
+0.89% | 6.02B | |
-4.31% | 4.28B | |
+11.12% | 4.04B |
- Stock Market
- Equities
- 1406 Stock
- News Clarity Medical Group Holding Limited
- Clarity Medical Group Holding Limited Provides Consolidated Earnings Guidance for the Six Months Ended 30 September 2022